2-Methoxyestradiol and hydrogen peroxide as promising promising biomarkers in Parkinson’s disease
OPUS Publication Server of the University of Stuttgart (University of Stuttgart) · 01.01.2023
DOI: 10.18419/opus-16960 ↗Kurz gefasst
Fachartikel in der Zeitschrift OPUS Publication Server of the University of Stuttgart (University of Stuttgart), erschienen am 01.01.2023. Verfasst von Paulina Bastian und 17 weiteren Autor:innen.
Abstract (Originalsprache)
Estrogens function in numerous physiological processes including controlling brain cell growth and differentiation. 2-Methoxestradiol (2-ME2), a 17β-estradiol (E2) metabolite, is known for its anticancer effects as observed both in vivo and in vitro. 2-ME2 affects all actively dividing cells, including neurons. The study aimed to determine whether 2-ME2 is a potentially cancer-protective or rather neurodegenerative agent in a specific tissue culture model as well as a clinical setup. In this study, 2-ME2 activity was determined in a Parkinson’s disease (PD) in vitro model based on the neuroblastoma SH-SY5Y cell line. The obtained results suggest that 2-ME2 generates nitro-oxidative stress and controls heat shock proteins (HSP), resulting in DNA strand breakage and apoptosis. On the one hand, it may affect intensely dividing cells preventing cancer development; however, on the other hand, this kind of activity within the central nervous system may promote neurodegenerative diseases like PD. Thus, the translational value of 2-ME2’s neurotoxic activity in a PD in vitro model was also investigated. LC-MS/MS technique was used to evaluate estrogens and their derivatives, namely, hydroxy and methoxyestrogens, in PD patients’ blood, whereas the stopped-flow method was used to assess hydrogen peroxide (H2O2) levels. Methoxyestrogens and H2O2 levels were increased in patients’ blood as compared to control subjects, but hydoxyestrogens were simultaneously decreased. From the above, we suggest that the determination of plasma levels of methoxyestrogens and H2O2 may be a novel PD biomarker. The presented research is the subject of the pending patent application “The use of hydrogen peroxide and 17β-estradiol and its metabolites as biomarkers in the diagnosis of neurodegenerative diseases,” no. P.441360.
Schlagwörter
Zitieren
APA
Bastian, P., Konieczna, L., Dulski, J., Daca, A., Jacewicz, D., Płoska, Agata, Knap, N., Sławek, Jarosław, Bączek, Tomasz, Kalinowski, Leszek, Drzeżdżon, J., Roszmann, A., Belka, M., & Górska‐Ponikowska, M. (2023). 2-Methoxyestradiol and hydrogen peroxide as promising promising biomarkers in Parkinson’s disease. OPUS Publication Server of the University of Stuttgart (University of Stuttgart). https://doi.org/10.18419/opus-16960
Vancouver
Bastian P, Konieczna L, Dulski J, Daca A, Jacewicz D, Płoska, et al. 2-Methoxyestradiol and hydrogen peroxide as promising promising biomarkers in Parkinson’s disease. OPUS Publication Server of the University of Stuttgart (University of Stuttgart). 2023. doi:10.18419/opus-16960
BibTeX
@article{Bastian2023,
author = {Bastian, Paulina and Konieczna, Lucyna and Dulski, Jarosław and Daca, Agnieszka and Jacewicz, Dagmara and Płoska and Agata and Knap, Narcyz and Sławek and Jarosław and Bączek and Tomasz and Kalinowski and Leszek and Drzeżdżon, Joanna and Roszmann, Anna and Belka, Mariusz and Górska‐Ponikowska, Magdalena},
title = {2-Methoxyestradiol and hydrogen peroxide as promising promising biomarkers in Parkinson’s disease},
journal = {OPUS Publication Server of the University of Stuttgart (University of Stuttgart)},
year = {2023},
doi = {10.18419/opus-16960}
}
EUVIMED